Associations between infiltrating lymphocyte subsets and hepatocellular Carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5909-5913

  Guo, Cun Li ^a   Yang, Hai Chao ^a   Yang, Xiu Hua ^a   Cheng, Wen ^a   Dong, Tian Xiu ^a   Zhu, Wen Jing ^a   Xu, Zheng ^a   Zhao, Liang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Regulatory T cells; Tumor microenvironment; Tumor Infiltrating lymphocytes

Indexed keywords

EID: 84874030780     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5909     Document Type: Article

References (26)

1. Chen CH, Lee HS, Huang GT, et al (2007). Phenotypic analysis of tumor infiltraring lymphocytes in hepatocellular carcinoma. Hepatogastroenterology, 54, 1529-33.
2. Chew V, Tow C, Teo M, et al (2010). Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol, 52, 370-9.
3. Fu J, Xu D, Liu Z, et al (2007). Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology, 132, 2328-39.
4. Gao Q, Qiu SJ, Fan J, et al (2007). Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol, 25, 2586-93.
5. Gehring AJ, Ho ZZ, Tan AT, et al (2009). Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology, 137, 682-90.
6. International Agency for Research on Cancer (2008). Liver cancer incidence and mortality worldwide in 2008. 2011; http://globocan.iarc.fr/factsheets/cancers/liver.asp.
7. Kasper HU, Drebber U, Stippel DL, et al (2009). Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol, 15, 5053-7.
8. Kobayashi N, Hiraoka N, Yamagami W, et al (2007). FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res, 13, 902-11.
9. Liakou CI, Narayanan S, Ng Tang D, et al (2007). Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immunity, 7, 10-5.
10. Li YW, Qiu SJ, Fan J, et al (2009). Tumor-infiltrating macro-phages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol, 135, 439-49.
11. Matkowski R, Gisterek I, Halon A, et al (2009). The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res, 29, 2445-51.
12. Nakano O, Sato M, Naito Y, et al (2001). Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res, 61, 5132-6.
13. Okada K, Komuta K, Hashimoto S, et al (2000). Frequency of apoptosis of tumour-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clin Cancer Res, 6, 3560-4.
14. Ohmura Y, Yoshikawa K, Saga S, et al(2008). Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. Oncol Rep, 19, 1265-70.
15. Pang YL, Zhang HG, Peng JR, et al (2009). The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunol Immunother, 58, 877-86.
16. Schumacher K, Haensch W, Róefzaad C, et al (2001). Prognostic significance of activated CD8 (+) T cell infiltrations within esophageal carcinomas. Cancer Res, 61, 3932-6.
17. Setiady YY, Coccia JA, Park PU (2010). In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol, 40, 780-6.
18. Shen X, Li N, Li H, et al (2010). Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage. J Cancer Res Clin Oncol, 136, 1745-54.
19. Shi F, Shi M, Zeng Z, et al (2011). PD-1 and PD-L1 upregulation promotes CD8 T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer, 128, 887-96.
20. Shirabe K, Kanematsu T, Matsumata T, et al (1991). Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology, 14, 802-5.
21. Shirabe K, Matsumata T, Maeda T, et al (1995). A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration: a clinicopathological study. Hepatogastroenterology, 42, 996-1001.
22. Smyth MJ, Teng MW, Swann J, et al (2006). CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol, 176, 1582-7.
23. Smyth MJ, Wallace ME, Nutt SL, et al (2005). Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med, 201, 1973-85.
24. Streuss L, Bergmann C, Whiteside TL (2009). Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol, 2, 1469-80.
25. Unitt E, Marshall A, Gelson W, et al (2006). Tumor lymphocyte infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol, 45, 178-81.
26. Wu K, Kryczek I, Chen L, et al (2009). Kupffer cell suppression of CD8 T cells in human hepatocellular carcinoma ismediated by B7-H1/programmed death-1 interactions. Cancer Res, 69, 8067-75.